Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 5/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 5/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 2/20 | 0.30 |
| ▸ | RAB9A | P51151 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4105848 | 0.97 | APP (0.48) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL10885090 | 0.97 | APP (0.48) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL3001162 | 0.97 | APP (0.48) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL51852 | 0.97 | — | — | |
| SCHEMBL11596772 | 0.94 | APP (0.50) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL11039416 | 0.94 | APP (0.50) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL9822644 | 0.94 | APP (0.50) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL10591208 | 0.94 | APP (0.50) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL841751 | 0.94 | APP (0.50) | APPLMNABLMPTGS1PDE4A | |
| SCHEMBL5888595 | 0.94 | APP (0.50) | APPLMNABLMPTGS1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118146124-A | Sulfonate containing ester group, preparation process and application thereof | 苏州祺添新材料股份有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-116396461-A | Isocyanate-terminated prepolymer, application thereof and polyurethane adhesive prepared from prepolymer | 北京大清生物技术股份有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-112912108-A | Cyclodextrin-based formulations of BCL-2 inhibitors | 法国施维雅药厂 | 2021-06-04 | — | — | CN | claimed |
| CN-111499547-A | Preparation method and application of alkyl ether sulfonyl fluoride compound | 江汉大学 | 2020-08-07 | — | — | CN | claimed |
| EP-1054664-A1 | METHOD FOR MODULATING MACROPHAGE ACTIVATION | Neurochem, Inc. (CA) | 2000-11-29 | — | — | EP | claimed |
| WO-1999040909-A1 | METHOD FOR MODULATING MACROPHAGE ACTIVATION | NEUROCHEM, INC. (CA) | 1999-08-19 | — | — | WO | claimed |
| CN-118146124-A | Sulfonate containing ester group, preparation process and application thereof | 苏州祺添新材料股份有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-115160191-B | Method for preparing alkylphenol polyoxyethylene ether sulfonate | 中国石油大学(华东) | 2024-04-26 | — | — | CN | disclosed |
| EP-3831388-B1 | CYCLOPENTENYL PURINE DERIVATIVE OR SALT THEREOF FOR USE IN SUPPRESSING ADENOVIRUS | FUJIFILM CORP (JP) | 2024-02-28 | — | — | EP | disclosed |
| US-20230382892-A1 | Chemical Compounds | PFIZER INC. (US) | 2023-11-30 | — | — | US | disclosed |
| US-20230295202-A1 | CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF | FUJIFILM CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| EP-3831836-B1 | CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF | FUJIFILM CORP (JP) | 2023-09-06 | — | — | EP | disclosed |
| US-11702405-B2 | Chemical compounds | PFIZER INC. (US) | 2023-07-18 | — | — | US | disclosed |
| US-5858326-A | CONTACTING AMYLOIDOGENIC PEPTIDE WITH AMYLOID-ENHANCING COMPOUND COMPRISING AROMATIC MOIETY AND AT LEAST TWO ANIONIC MOIETIES IN VITRO TO FORM AMYLOID FIBRILS | NEUROCHEM, INC. (CA) | 1999-01-12 | — | — | US | disclosed |
| US-5728375-A | ADMINISTERING A COMPOUND COMPRISING AN ANIONIC GROUP AND A CARRIER MOLECULE; INHIBITS DEPOSITION BY PREVENTING INTERACTION BETWEEN AN AMYLOIDOGENIC PROTEIN AND A BASEMENT MEMBRANE CONSTITUENT | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1998-03-17 | — | — | US | disclosed |
| US-5643562-A | ANTIDEPOSIT AGENTS FOR PROTEINS FOR MEDICAL DIAGNOSIS OF DISEASES | QUEEN'S UNIVERSITY OF KINGSTON (CA) | 1997-07-01 | — | — | US | disclosed |
| EP-0062430-B1 | PROCESS FOR THE PREPARATION OF (OMEGA-FLUOROSULFONYL) HALOALIPHATIC CARBOXYLIC ACID FLUORIDES | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1986-11-12 | — | — | EP | disclosed |
| US-4466881-A | ELECROLYTIC FLUORINATION | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1984-08-21 | — | — | US | disclosed |
| US-4425199-A | FLUORINATION, ELECTROLYSIS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1984-01-10 | — | — | US | disclosed |
| EP-0062430-A1 | Process for the preparation of (omega-fluorosulfonyl) haloaliphatic carboxylic acid fluorides | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1982-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295202-A1 | CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF | SLC28A1, SLC20A1, SLC29A1 | APP 2279/4885LMNA 2968/4885BLM 532/4885 |
| US-11702405-B2 | Chemical compounds | HBZ, HBB, HBS1L | APP 1293/4885LMNA 748/4885BLM 1630/4885 |
| US-20230382892-A1 | Chemical Compounds | HBZ, HBB, HBS1L | APP 1293/4885LMNA 748/4885BLM 1630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.